Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Haider Al-Janabi"'
Autor:
Christopher Bailey, Johann De Bono, Munitta Muthana, Mateus Crespo, Bora Gurel, Pasquale Rescigno, Matthew Fisher, Wayne A Phillips, Richard Allen, Harry Nunns, Janet E Brown, Haider Al-janabi, Katy Moyes, Anna Junker-Jensen, Helen B Pearson, Mary-Ellen Taplin, Claire E Lewis
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 7 (2024)
Background Androgen deprivation therapy (ADT) is a front-line treatment for prostate cancer. In some men, their tumors can become refractory leading to the development of castration-resistant prostate cancer (CRPC). This causes tumors to regrow and m
Externí odkaz:
https://doaj.org/article/2f9585a571b74710badae3f4850ddc0f
Autor:
Munitta Muthana, Joe Conner, Sarah J. Danson, Janet E. Brown, Claire E. Lewis, Graham Pockley, Jayakumar Vadakekolathu, Penelope Ottewell, Sanjay Srivastava, Simon J. Tazzyman, Taewoo Kim, Adam Wilshaw, Joshua Handley, Katie Cox, Drew Capper, Matthew Hutchinson, Dhanajay Evans, Rikah Louie, Mohammed Moamin, Russell Hughes, Richard J. Allen, Haider Al-Janabi, Emer Atkinson, Natalie Winder, Amy Kwan
Supplementary Tables and Figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a95db13d525e2373f8c7096de989a19
https://doi.org/10.1158/1535-7163.22521123
https://doi.org/10.1158/1535-7163.22521123
Autor:
Russell Hughes, Graham Pockley, Mohammed Ridha Moamin, Joe Conner, Sanjay K. Srivastava, Natalie Winder, Simon Tazzyman, Joshua Handley, Munitta Muthana, Adam Wilshaw, Dhanajay Evans, Richard J. Allen, Rikah Louie, Claire E. Lewis, Haider Al-Janabi, Amy Kwan, Katie Cox, Jayakumar Vadakekolathu, Sarah Danson, Janet E. Brown, Taewoo Kim, Penelope D. Ottewell, Drew Capper, Emer Atkinson, Matthew Hutchinson
Publikováno v:
Molecular Cancer Therapeutics. 20:589-601
Oncolytic viruses (OV) have been shown to activate the antitumor functions of specific immune cells like T cells. Here, we show OV can also reprogram tumor-associated macrophage (TAM) to a less immunosuppressive phenotype. Syngeneic, immunocompetent
Autor:
Faith H N Howard, Haider Al‐Janabi, Priya Patel, Katie Cox, Emily Smith, Jayakumar Vadakekolathu, A. Graham Pockley, Joe Conner, James F Nohl, Dan A Allwood, Cristal Collado‐Rojas, Aneurin Kennerley, Sarah Staniland, Munitta Muthana
The survival strategies of infectious organisms have inspired many therapeutics over the years. Indeed the advent of oncolytic viruses (OVs) exploits the uncontrolled replication of cancer cells for production of their progeny resulting in a cancer-t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7307e33081b48853c26f8594883cb07b
https://eprints.whiterose.ac.uk/183446/1/Small_2022_Howard_Nanobugs_as_Drugs_Bacterial_Derived_Nanomagnets_Enhance_Tumor_Targeting_and_Oncolytic_Activity_of.pdf
https://eprints.whiterose.ac.uk/183446/1/Small_2022_Howard_Nanobugs_as_Drugs_Bacterial_Derived_Nanomagnets_Enhance_Tumor_Targeting_and_Oncolytic_Activity_of.pdf
Publikováno v:
The International Arab Journal of Information Technology. 19
The paper discusses the issue of creating a secure environment for information transmission in an association dependent on Noticeable Light Correspondence (VLC) innovation utilizing a Power Line Correspondence (PLC) modem. Throughout the examination,
Publikováno v:
International Journal of Pharmaceutics. 555:322-336
The lack of efficient and cost-effective methods for gene delivery has significantly hindered the applications of gene therapy. In this paper, a simple one step and cost effective salting-out method has been explored to fabricate silk-PEI nanoparticl
Autor:
Claire E. Lewis, Haider Al-Janabi
Publikováno v:
Cancer Research. 81:5399-5400
Androgen deprivation therapy (ADT) is the front-line treatment for early and metastatic prostate cancer, and the development of tumor resistance to it has major clinical consequences. Cancer cells start to proliferate and tumors begin to regrow, requ
Autor:
Munitta Muthana, Mateus Crespo, Ning Wang, Xuan Pu, Haider Al-Janabi, Bora Gurel, Claire E. Lewis, Janet E. Brown, Johann S. de Bono
Publikováno v:
Cancer Research. 81:2797-2797
Men with intermediate/high-risk, localized prostate cancer usually receive neoadjuvant androgen deprivation therapy (ADT). Although this markedly reduces tumor burden, it may not be curative and over time cancer cells develop resistance to ADT causin
Publikováno v:
Cancer Research. 79:LB-136
Background: Men with intermediate/high-risk, localised prostate cancer are usually offered androgen deprivation therapy (ADT) and if this fails, radical prostatectomy. Men understandably prefer not to have the latter where possible as it often leads